Citation Impact
Citing Papers
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Effects of inflammatory and anti‐inflammatory cytokines on the bone
2011
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine
1997
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men
1998
Inflammation-Induced Bone Loss: Can it Be Prevented?
2006
Acromegaly
2006 Standout
Guide to Bone Health and Disease in Cystic Fibrosis
2005
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Growth Hormone, Exercise, and Aging: The Future of Therapy for the Frail Elderly
1994
Inhaled Corticosteroids
2003
Bone mineral density in acromegaly: Does growth hormone excess protect against osteoporosis?
2001
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor–transgenic mice
2003
Effect of Enhancement of Endogenous Cholinergic Tone with Pyridostigmine on the Dose-Response Relationships of Growth Hormone (GH)-Releasing Hormone-Induced GH Secretion in Normal Subjects*
1990
New therapies for treatment of rheumatoid arthritis
2007
Rheumatoid arthritis
2016 Standout
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial
2008
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
2001
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Development of TLR inhibitors for the treatment of autoimmune diseases
2008
Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
2006
Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor κB Ligand: Clinical Utility in Metabolic Bone Disease Assessment
2005
Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
2012
Bone mineral density and circulating cytokines in patients with acromegaly
1998
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
1993
Hallmarks of aging: An expanding universe
2023 Standout
OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
2006
Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
2005
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*
1991
A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
2002
Autophagy and senescence, converging roles in pathophysiology as seen through mouse models
2021
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Vitamin D Deficiency
2007 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Chronic pediatric inflammatory diseases: Effects on bone
2007
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
2005
Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type
1989
Growth hormone and metabolism
1988
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
2005
Reduced Efficacy of Growth Hormone-Releasing Hormone in Modulating Sleep Endocrine Activity in the Elderly
1997
Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender
1998
Robust Growth Hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH)
1991
Human Growth Hormone and Human Aging
1993
Metabolic Clearance Rates of Synthetic Human Growth Hormone in Lean and Obese Male Rhesus Monkeys*
1988
GROWTH HORMONE RESPONSE TO GROWTH HORMONE RELEASING FACTOR IN DIABETIC MEN
1988
CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs
1999 Standout
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
1998
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor–mediated arthritis
2004
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
2003
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients
1994
Telomere length versus hormonal and bone mineral status in healthy elderly men
2005
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Osteoclast differentiation and activation
2003 StandoutNature
Defective Hypothalamic Growth Hormone (GH)-Releasing Hormone Activity May Contribute to Declining GH Secretion with Age in Man1
1997
Additive bone‐protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models
2005
The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade
2001
THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
1997
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients
1993
A longitudinal study of the relationship between periodontal disease and bone mineral density in community‐dwelling older adults
2004
Hypothalamic Mediation of Reduced GH Secretion in Diabetic Rats: Evidence for Reduced Cholinergic Inhibition of Somatostatin Release
1995
Hypovitaminosis D is associated with insulin resistance and β cell dysfunction
2004
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Characterization of transendothelial chemotaxis of T lymphocytes
1995
GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES
1988
Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis
2007
Therapeutic strategies for rheumatoid arthritis
2003
Predictors of bone mineral density in patients on hemodialysis
2004
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
2005
No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients
1997
Osteoporosis after solid organ and bone marrow transplantation
2003
Production and Actions of Estrogens
2002 Standout
Differential Effects of E and Droloxifene on C-Reactive Protein and Other Markers of Inflammation in Healthy Postmenopausal Women
2001
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
1999
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
Immunologic aspects of osteoporosis
1997
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis
2008
Growth hormone neuroregulation in diabetes mellitus
1994
Factors Influencing Survival following Surgical Treatment of Obesity
2005
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients
2002
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
2013
Osteoporosis in the elderly with chronic kidney disease
2006
Hypothalamic control of growth hormone (GH) secretion in type i diabetic men: Effect of the combined administration of gh-releasing hormone and hexarelin, a novel GHRP-6 analog.
1996
miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
2010
Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Osteoporosis in Men
2008
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis
2004
Osteoclasts are essential for TNF-α–mediated joint destruction
2002
The Complex Role of Estrogens in Inflammation
2007 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Gonadal status is an important determinant of bone density in acromegaly
1998
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women
2005
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Telomere length is paternally inherited and is associated with parental lifespan
2007 StandoutNobel
Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin.
1988
Growth hormone secretion after the administration of GHRP‐6 or GHRH combined with GHRP‐6 does not decline in late adulthood
1995
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Sexual dimorphism of the somatotrophic axis
1998
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Osteoclasts and Arthritis
2009
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Impaired Collateral Vessel Development Associated With Reduced Expression of Vascular Endothelial Growth Factor in ApoE −/− Mice
1999
In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease
2002
Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy
2002
Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.
1991 StandoutNobel
T CELL MEMORY
1998
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
1992
Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross-Sectional Study in Postmenopausal Women
2005
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Serum 25-Hydroxyvitamin D3 Concentrations and Prevalence of Cardiovascular Disease Among Type 2 Diabetic Patients
2006
Osteoclasts are essential for TNF-α–mediated joint destruction
2002
Sex differences in growth hormone response to growth hormone-releasing hormone
1991
Engagement of distinct epitopes on CD 43 induces different co‐stimulatory pathways in human T cells
2016
Interaction between Synovial Inflammatory Tissue and Bone Marrow in Rheumatoid Arthritis
2005
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Adverse events associated with hormonal therapy for prostate cancer.
2005
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Arthritis Induces Lymphocytic Bone Marrow Inflammation and Endosteal Bone Formation
2004
Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
2005
Age-Dependent Impairment of Angiogenesis
1999
Skeletal Involvement in Female Acromegalic Subjects: The Effects of Growth Hormone Excess in Amenorrheal and Menstruating Patients
1997
Osteoporosis in Men*
1999
Bone metabolism and disease in chronic kidney disease
2003
Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin
2000
Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?
1996
Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
2007
Works of Peter Pietschmann being referenced
Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation
2008
Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures
1989
Apolipoprotein (a) Levels and Atherogenic Lipid Fractions in Relation to the Degree of Urinary Albumin Excretion in Type 2 Diabetes mellitus
1994
Serum levels of osteoprotegerin increase with age in a healthy adult population
2003
The Effect of Age on the Transendothelial Migration of Human T Lymphocytes
1996
Interaction of Triiodothyronine With 1α,25-Dihydroxyvitamin D3 on Interleukin-6-Dependent Osteoclast-like Cell Formation in Mouse Bone Marrow Cell Cultures
1998
A comparison of quantitative computed tomography and dual x-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis
2001
Regulatory Effects of 1α,25-Dihydroxyvitamin D3on the Cytokine Production of Human Peripheral Blood Lymphocytes1
1999
Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
2002
Immune phenotype and intracellular cytokine production of peripheral blood mononuclear cells from postmenopausal patients with osteoporotic fractures
2001
Alendronate for the Treatment of Osteoporosis in Men
2000
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus
1995
Rheumatoid arthritis synovium contains plasmacytoid dendritic cells
2005
Decreased Serum Osteocalcin Levels in Phenprocoumon-Treated Patients
1988
Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures
1990
Osteoporosis: An Age-Related and Gender-Specific Disease – A Mini-Review
2008
The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium
1992
The Role of Cathepsins in Osteoimmunology
2013
Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications
1988
Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics
1993
Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis
1992
High turnover bone disease following lung transplantation
1998
Broadband ultrasound attenuation: a new diagnostic method in osteoporosis.
1990
Bone Metabolism in Patients with Functioning Kidney Grafts: Increased Serum Levels of Osteocalcin and Parathyroid Hormone Despite Normalisation of Kidney Function
1991
The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density
1992
Enhanced Growth Hormone Responses to Growth Hormone Releasing Hormone in Male Type I Diabetic Patients
1991
Bone mineral density and parameters of bone metabolism in patients with acromegaly
1993
Effects of Sex and Age on Growth Hormone Response to Growth Hormone-Releasing Hormone in Healthy Individuals
1987
Effect of growth hormone releasing hormone on growth hormone secretion in Type 2 (non-insulin-dependent) diabetes mellitus
1987
Effect of Cholinergic Muscarinic Receptor Blockade on Human Growth Hormone(GH)-Releasing Hormone-(l-44)-Induced GH Secretion in Acromegaly and Type I Diabetes Mellitus
1986
Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC)
2012
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.
2002
Identification of subsets of human T cells capable of enhanced transendothelial migration
1992
No Evidence For Increased Growth Hormone Responses to Growth Hormone-Releasing Hormone in Patients With Diabetic Retinopathy
1987
17β-Estradiol Antagonizes Effects of 1α,25-Dihydroxyvitamin D3 on Interleukin-6 Production and Osteoclast-Like Cell Formation in Mouse Bone Marrow Primary Cultures*
1997
Increased serum osteocalcin levels in patients with lactase deficiency.
1991